Drawing for THRIVEX

USPTO serial 98747838

THRIVEX

Reviewed by CopyMark Law Group

Status 688Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
KEAM, ALEX S
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 688: Status 688 means a Notice of Allowance was issued. For intent-to-use applications, you must file a Statement of Use with specimens or request an extension before the deadline — usually six months from the notice date.

Need help with THRIVEX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $299*

Plus Government fees of $125

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Dineen Pashoukos Wasylik

Dineen Pashoukos Wasylik DPW Legal2244 Green Hedges Way, Suite 101Wesley Chapel, FL 33544United States

Goods and services

ClassDescriptionStatusFirst use
005(Based on intent to use): Dietary supplements; Dietary and nutritional supplements used for weight loss; Homeopathic supplements; Nutritional supplementsACTIVE—
035(Based on use in commerce): On-line retail store services featuring a wide variety of consumer goods of others; Online retail store services rendered in a virtual environment featuring physical goods, namely, nutritional supplements; Online retail store services rendered in a virtual environment featuring physical goods, namely, home medical tests; Online retail store services rendered in a virtual environment featuring physical goods, namely, personal care items, namely, sunscreen, pain relief products, skin care, hair care productsACTIVESep 4, 2015
044(Based on use in commerce): Cancer screening services; Concierge medicine services; Intravenous (IV) hydration therapy services; Intravenous (IV) vitamin therapy services; Medical diagnosis and treatment of cancer; Medical diagnosis and treatment of food sensitivity; Medical diagnosis and treatment of neurodegenerative disorders; Weight management services, namely, providing weight loss and/or weight maintenance programs; Providing weight loss program servicesACTIVESep 4, 2015

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (NOAM): A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.

DateCodeEventWhat it means
Mar 24, 2026NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 12, 2026ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Jan 27, 2026EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Aug 21, 2025ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Aug 5, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 5, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 30, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 30, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 30, 2025XAECEXAMINER'S AMENDMENT ENTERED—
Jun 30, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 30, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 30, 2025CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 24, 2025ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Jun 17, 2025PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
May 20, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 19, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 19, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 19, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 4, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 4, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 4, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 3, 2025LOPRLETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN—
Feb 28, 2025DOCKASSIGNED TO EXAMINER—
Jan 27, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 15, 2024LOPTLETTER OF PROTEST EVIDENCE FORWARDED—
Sep 12, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance